AliveCor develops personal electrocardiogram technologies that apply machine learning to improve traditional ECG analysis. The collaboration will integrate Mayo Clinic’s patented algorithms into AliveCor’s portable Kardia Mobile ECG monitor to enable early detection of long QT syndrome without visiting a hospital or physician’s office.
“This agreement makes our vision of universal screening for the early detection of long QT syndrome — a potentially lethal, yet highly treatable condition — one step closer to reality,” said Michael J. Ackerman, MD, PhD, director of Mayo Clinic’s Windland Smith Rice Sudden Death Genomics Laboratory. “Any of these deaths could be averted with simple preventive and/or counteractive measures.”
More articles on health IT:
Allscripts partners with Conversa for clinical conversation platform
Congressional App Challenge names director
Kalorama: Physician frustration drives regular EMR vendor switching
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
